Joint Corp. reports Q1 EPS 9c, consensus 3c

Reports Q1 revenue $14.82M, consensus $14.5M. “During the first quarter of 2026, we continued to build a more efficient and profitable platform, advancing our refranchising efforts, optimizing our clinic portfolio, and tightening our operating structure across the system,” said President and Chief Executive Officer of The Joint Corp. (JYNT), Sanjiv Razdan. “In April, we entered into an agreement for the sale of 45 of our company-owned or managed clinics, effectively completing our Joint 2.0 refranchising initiative, with fewer than 1% of our remaining clinic portfolio being company-owned or managed. At the same time, we remain active with our capital allocation priorities with continued share repurchases, as well as the recent completion of three regional developer buybacks that further optimize our portfolio economics.”